Intrexon | XON - 税前利润





税前利润 更改 日
Agenus USD -10.61M 263.52M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
Amgen USD 3.92B 2.35B 2025-09
Anika Therapeutics USD 764K 3M 2025-12
Arrowhead Research USD 28.27M 7.85M 2025-12
AstraZeneca USD 3.24B 117M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Gilead Sciences USD 3.64B 1.21B 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Incyte USD 389.94M 92.37M 2025-12
Intrexon USD -60.48M 27.09M 2024-06
Karyopharm Therapeutics USD -30.89M 1.16M 2024-12
Ligand Pharmaceuticals USD 141.14M 102M 2025-09
MacroGenics USD -14.93M 31.75M 2025-12
MannKind USD -20.93M 28.71M 2025-12
Merck USD 6.74B 22M 2025-09
Novartis USD 4.64B 445M 2025-12
Rigel Pharmaceuticals USD -1.03M 7.22M 2024-06
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veracyte USD 40.63M 21.74M 2025-12
Xencor USD -4.27M 1.76M 2025-12